Lexicon Pharmaceuticals Inc (LXRX)

May 04, 2026

Lexicon secures $100m loan facility with Hercules Capital - Investing.com UK

May 04, 2026

May 04, 2026

Lexicon secures $100m loan facility with Hercules Capital By Investing.com - Investing.com South Africa

May 04, 2026

May 04, 2026

[Form 4] LEXICON PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals (LXRX) director receives new option and RSU awards - Stock Titan

May 04, 2026

May 04, 2026

Lexicon (NASDAQ: LXRX) director awarded stock options and 35,714 RSUs - Stock Titan

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals (LXRX) director receives new options and RSUs - Stock Titan

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals (NASDAQ: LXRX) director receives new option and RSU awards - Stock Titan

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital - The Manila Times

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals (LXRX) director receives new option and RSU grants - Stock Titan

May 04, 2026

May 04, 2026

Lexicon Pharmaceuticals secures $100 million loan facility with Hercules Capital - StreetInsider

May 04, 2026

May 04, 2026

$55M upfront helps Lexicon repay debt under new $100M loan - Stock Titan

May 04, 2026

May 03, 2026

Earnings call transcript: Lexicon Pharmaceuticals beats Q4 2025 expectations - Investing.com

May 03, 2026

May 02, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200-Day Moving AverageHere's What Happened - MarketBeat

May 02, 2026

May 02, 2026

Lexicon Pharmaceuticals (LXRX) to Release Earnings on Thursday - MarketBeat

May 02, 2026

May 02, 2026

Earnings Preview: LXRX to Report Financial Results Pre-market on May 07 - Moomoo

May 02, 2026

May 01, 2026

Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851 - Insider Monkey

May 01, 2026

Apr 30, 2026

Lexicon Pharmaceuticals | 8-K: Current report - Moomoo

Apr 30, 2026

Apr 30, 2026

Lexicon (NASDAQ: LXRX) expands share pools and converts Series B preferred - Stock Titan

Apr 30, 2026

Apr 30, 2026

Lexicon Pharmaceuticals (LXRX) price target increased by 15.07% to 3.43 - MSN

Apr 30, 2026

Apr 30, 2026

Lexicon schedules May 7 webcast to discuss its Q1 results - Stock Titan

Apr 30, 2026

Apr 30, 2026

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - The Manila Times

Apr 30, 2026

Apr 27, 2026

Lexicon flags $10 mln Novo Nordisk milestone and 2026 NDA plans - MSN

Apr 27, 2026

Apr 27, 2026

Lexicon Pharmaceuticals prices $94.6M share offering - MSN

Apr 27, 2026

Apr 27, 2026

LXRX Stock Chart | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - ChartMill

Apr 27, 2026

Apr 27, 2026

How The Lexicon Pharmaceuticals (LXRX) Investment Story Is Shifting With Pilavapadin And LX9851 - Yahoo Finance

Apr 27, 2026

Apr 26, 2026

Lexicon reports FDA's decision to extend review period for Zynquista - MSN

Apr 26, 2026

Apr 25, 2026

Lexicon’s Stock Ran On Partnerships, Not INPEFA Sales - Finimize

Apr 25, 2026

Apr 24, 2026

Lexicon Pharmaceuticals Moves Pilavapadin to Phase 3 Development - HarianBasis.co

Apr 24, 2026

Apr 24, 2026

Lexicon Pharmaceuticals presents Phase 2b results supporting 10 mg dose in DPNP at AAN 2026 - Traders Union

Apr 24, 2026

Apr 24, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat

Apr 24, 2026

Apr 23, 2026

Lexicon Pharmaceuticals (LXRX) to Present Phase 2b Pilavapadin Data - Insider Monkey

Apr 23, 2026

Apr 21, 2026

LXRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026

Apr 21, 2026

SONATA-HCM Phase 3 clinical trial accelerates HCM drug research for Lexicon Pharmaceuticals - Traders Union

Apr 21, 2026

Apr 21, 2026

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 earnings call transcript - MSN

Apr 21, 2026

Apr 17, 2026

Significant First Quarter Growth for LXRX Driven by New Client R - GuruFocus

Apr 17, 2026

Apr 17, 2026

Lexicon (LXRX) Advances Pilavapadin After Positive Phase 2b Stud - GuruFocus

Apr 17, 2026

Apr 17, 2026

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting - The Manila Times

Apr 17, 2026

Apr 17, 2026

New Lexicon data back a 10 mg diabetic nerve pain dose for Phase 3 - Stock Titan

Apr 17, 2026

Apr 16, 2026

Lexicon Pharmaceuticals (LXRX) Stock Weekly Analysis (Smart Money Outflows) 2026-04-16Community Pattern Alerts - Cổng thông tin điện tử Tỉnh Sơn La

Apr 16, 2026

Apr 16, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 1-Year HighHere's Why - MarketBeat

Apr 16, 2026

Apr 13, 2026

How does macroeconomics affect Lexicon Pharmaceuticals (LXRX) Stock | LXRX Q4 Earnings: Beats Estimates by $0.03Regulatory Risk - Cổng thông tin điện tử tỉnh Lào Cai

Apr 13, 2026

Apr 12, 2026

Lexicon Pharmaceuticals Q2 2025 Earnings Preview - MSN

Apr 12, 2026

Apr 11, 2026

Growth Report: What is the target price for Lexicon Pharmaceuticals Inc stock2026 Update & Weekly High Return Opportunities - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

IPO Launch: Is Lexicon Pharmaceuticals Inc stock trending bullish2026 Key Lessons & Intraday High Probability Alerts - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

LXRX SEC FilingsLexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 10, 2026

Apr 10, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week HighShould You Buy? - MarketBeat

Apr 10, 2026